1-fluornaftalen

Runze Pharmaceutical (Suzhou) Co.,LTD.,established in June 2003, is a progressive pharmaceutical corporation invested by Shandong Runze & Ruiying Parmaceutical Group.

The company has 12 production subsidiaries in Shandong headquarters.

Shandong Ruiying Pioneer Pharmaceutical Co., Ltd., originally known as Heze Ruiying Pharmaceutical Group Co., Ltd., is a large medicine manufacturer integrating scientific research, pilot plant test, manufacturing and sales, covering biological fermentation, chemical synthesis, aseptic pharmacy, etc. and forming complete industrial chain. The company now has 1,500 employees, above 40% of which are various professional technicians. With global advanced technical level, it has 95% products developed independently, partially filling in the domestic blanks. It has passed the certifications of Quality Management System, Goods Manufacturing Practice (GMP) of State Food and Drug Administration, EHS and South Korea KFDA and possessed proprietary import and export rights. Besides domestic market, it has tapped the markets of dozens of countries in Europe and America.

Powerful in scientific research strength, it has a high-level R&D team cored with doctors, masters and part foreign experts. A large amount of first-class high-tech products have been researched and developed, including 30 scientific research achievements with provincial appraisal and many rewards and 8 domestically unique projects with international advanced level.